ClinicalTrials.Veeva

Menu

Prospective, Post Market Surveillance Q3-registry (POLARIS) (Q3-Registry)

Q

QualiMed

Status

Unknown

Conditions

Peripheral Artery Disease

Treatments

Device: POLARIS Peripheral Vascular Self Expanding Stent System

Study type

Observational

Funder types

Industry

Identifiers

NCT02307292
QualiMed

Details and patient eligibility

About

This is a prospective, non-randomized post market surveillance registry designed to document the clinical Performance in Routine clinical practice of the POLARIS Peripheral Vascular Self Expanding Stent System

Enrollment

250 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18 years
  • Single target de novo superficial femoral artery lesion (angiographic evidence of >50% Stenosis or occlusion) by visual estimate
  • Rutherford category II-IV
  • At least one patent outflow artery to the ankle.
  • Patient signed the informed consent

Exclusion criteria

  • Patient with acute or subacute Thrombus
  • Patients with hyperkoagulopathy
  • Patients with Stenosis or occlusion where lesion crossing with guide wire is not possible
  • Pregnancy or positive pregnancy test
  • Previous enrolment in this Trial or other industrial Trials
  • Patient´s inability to fully cooperate with the registry protocol Patient with cancer Treatment (life expectancy less than 2 years) Patients with renal failure

Trial contacts and locations

1

Loading...

Central trial contact

Sigrid Krimmer-Quendler, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems